Orbis Board Members

John is an operating partner at Stonepeak, a leading alternative investment firm, and is Chairman at Forgital Group, a manufacturer of aerospace and industrial forged components. John also serves on the board of NYSE-listed BETA Technologies.

John is a Fellow of The Royal Aeronautical Society, President Emeritus of The Wings Club Foundation, and a former Board Governor of the Smithsonian's National Air and Space Museum.

John holds a BA from the University of Glamorgan, an MBA from the University of Limerick (UL), completed the Advanced Management Program at Harvard Business School, and is an adjunct professor at UL’s Kemmy Business School, where he also received an Honorary Doctorate in Economic Science.

Dr. Friedman has over 450 publications in peer-reviewed journals and was listed as one of the 100 most influential ophthalmologists on the PowerList on several occasions. He was elected to the Alcon Research Institute, which includes the top six ophthalmic researchers each year, and is a member of the Glaucoma Research Society and the Academia Ophthalmologica Internationalis, each of which is limited to 100 invited members considered to be leaders in ophthalmology and research. He has served as a Board of Governor member for the World Glaucoma Association. Dr. Friedman has published seminal articles in glaucoma adherence to therapy, population-based glaucoma screening, and the treatment of angle closure glaucoma.

He was named New Inventor of the Year for the University of Colorado in 2009 and Inventor of the Year for 2010. Dr. Kahook has also received the American Glaucoma Society Innovator Award (2020), the American Academy of Ophthalmology Achievement Award in 2011, the American Academy of Ophthalmology Senior Achievement Award in 2017, the American Academy of Ophthalmology Secretariat Award (2014), the Ludwig Von Sallmann Clinician-Scientist Award (ARVO) in 2013 and was ranked second on the 40 under 40 Ophthalmology Power List (2015). He was named to the annual top ten list of The Ophthalmologist "Power 100" List in 2020-2024. Dr. Kahook has filed for over 140 patents, with over 60 licensed by companies including New World Medical, Alcon, ClarVista Medical, and SpyGlass Pharma for development and commercialization. Several of his devices are currently in human trials or available globally for clinical use including the Kahook Dual Blade from New World Medical and the Harmoni modular intraocular lens system from ClarVista Medical which was acquired by Alcon. Dr. Kahook serves as Chair of Orbis International’s Medical Advisory Committee and is a consultant to the Food and Drug Administration’s Ophthalmic Device Division.

Diana joined the Orbis Board in April 2011 and was named Secretary in November 2011. She is also a member of the Nominating and Governance, Finance, and the Executive Committees. In addition, Diana has been a member of the Board of New England Law – Boston since 1998, where she has served on Compensation, Endowment, Audit, and Search Committees. Diana served as Vice-Chairman of that Board for several years and as Chairman of the Board in 2020 – 2021. She received her Juris Doctorate degree from New England Law in 1990. In December 2021, Diana was appointed by Bishop Andrew Dietsche to serve as a Trustee of the Episcopal Diocese of New York (“EDNY”). She also serves on the Real Estate, Risk Management, and Audit Committees and is Co-Chairman of the Human Resources Committee of EDNY.

Prior to her current role, Julie spent 10 years in Pfizer’s manufacturing and supply division where she developed an interest in the intersection of technology, supply chain and public health. She has worked at three of Pfizer’s manufacturing sites and still partners extensively with the internal and external supply network.

Julie holds a Master’s in Public Health from Columbia University and BA in Supply Chain Management from Michigan State University.

Since 1994 when Mr. Attias joined Alcon, he has had various roles with increasing responsibility beginning with positions in Alcon’s Sales and Marketing functions and then holding the positions of Vice President, Refractive Sales and Marketing from 2002 to 2007; Vice President/General Manager of Alcon Canada from 2007 to 2009; Vice President, Central & Eastern Europe, Italy and Greece from 2009 to 2010; and President, Europe, Middle East and Africa (EMEA) from 2010 to 2012.

From 2012 to 2015, as Senior Vice President of Global Commercial Franchises, Mr. Attias led all commercial execution and product pipeline activities of Alcon’s Surgical, Pharmaceutical and Vision Care franchises. Mr. Attias holds both a Bachelor of Business Administration in Marketing and a Master of Business Administration from Texas Christian University in the United States.

In addition, Justin led the Airline Technology team that is responsible for the continued modernization of airline IT systems, and research and development efforts that support the latest innovations in aviation technology. A 22-year industry veteran and three-time recipient of the FedEx Express Five Star Award, Justin has held several leadership positions at FedEx Express. As Vice President

of Base and Propulsion Maintenance, his responsibilities included airframe Heavy Maintenance, Global Maintenance Operations Control, and Maintenance Planning. As Managing Director of Propulsion Maintenance, Justin oversaw technical and commercial management of 1,400 engines and APUs for the entire FedEx Express jet aircraft fleet, including sourcing and negotiation of engine maintenance agreements. Prior to this role, he managed Base Maintenance Business Planning and was an engineer in Aircraft Powerplant Engineering. Justin earned a bachelor’s degree in mechanical engineering and a master’s degree in business administration from Christian Brothers University School of Engineering in Memphis, Tenn. Justin also serves on the board of directors for Orbis International, an organization battling preventable blindness around the world using aviation and technology. Justin’s life-long love of aviation and engineering was instilled by his grandfather, who was an engineer and a pilot. Justin currently resides in Memphis, Tenn. with his wife Melissa and their children, Will, Nate, and Julia.

Mr. Howitt also has considerable experience in bank and private placement credit transactions, including asset-based financings; domestic and Latin American debt restructurings; acquisition and recapitalization financings; domestic, Eurodollar, and Eurocurrency loans; loan and note swaps; sales and participations; letter of credit facilities; and commercial paper facilities. Mr. Howitt is a recognized leading lawyer in aviation finance and in equipment finance generally, ranked in Band 1 in both practice areas in the 2019 edition of Chambers USA (Nationwide – Transportation: Aviation Finance; New York – Banking and Finance: Equipment Finance & Leasing). Quoting Chambers, Mr. Howitt is "considered 'a leader in the aviation finance space; he is fantastic when it comes to synthesizing complex issues into realistic advice. Mr. Howitt received his BA degree, magna cum laude, Phi Beta Kappa, in 1975 from the University of California at Los Angeles, where he also received his JD degree in 1978. He was a member of the Order of the Coif and the UCLA Law Review.

He also is a proven digital health investor and was a founding investor in both Epocrates and Doximity, industry-leading mobile apps for physicians used by over 70% of ophthalmologists. Gil is a co-founder and program director of Eyecelerator, a first-of-kind, ophthalmology innovation conference supported by a joint venture of the American Academy of Ophthalmology and the American Society of Cataract and Refractive Surgery. Previously, he helped to launch Ophthalmology Innovation Summit (OIS), an ophthalmology business conference where he was an advisor and founding co-chairman from 2009-2019. A former practicing ophthalmologist, Gil completed an ophthalmology residency at Wills Eye Hospital and a retina fellowship at Massachusetts Eye and Ear Infirmary as a Heed Foundation Fellow. Gil has a B.A. from Harvard University, an M.D. from the University of Pennsylvania, and an M.B.A. from Stanford University. He also serves as a National Trustee for the Foundation Fighting Blindness and is a member of the Medical Strategy Committee of Orbis International.

Jim earned a bachelor’s degree in economics and fine arts from St. Lawrence University, and an MBA from Fordham University. He holds Series 7, 9, 10 and 65 licenses. Jim is an active member of his community, and served as president of the Greenwich Skating Club, and the Staunton Farm Foundation. He is currently the President of the Round Hill Club.

He worked well as a team member with other corporate officers and leaders. Ken’s greatest satisfaction was to have happy customers and teammates. Ken earned his CPA at Price Waterhouse before joining FlightSafety. He earned his BS in accounting at Lehigh University.

Previously, he served as the executive team member leading the strategy and operations for pre-launch and global commercialization of a first-in-class biologic at ThromboGenics. Over the span of his career, Dr. Palanki has held roles of increasing responsibility at several small, mid-sized and large companies, including the launch of LUCENTIS® at Genentech.

He is an active board member and strategic advisor to publicly traded and private biotech companies, technology start-ups and global non-profits. Ram holds a PharmD from Albany College of Pharmacy, Union University, NY, and his post doctorate from Rutgers University, NJ.

Prior to joining Resideo, Adrian built his career at Honeywell beginning in 1980. In that time, he led customer service and product support for Aerospace, Automation and Control Solutions, and the Home and Building Technologies businesses. In addition to his Board role with Orbis International, Paull also serves on the Advisory Board for Arizona State University’s Center for Services Leadership, and the Board for Televerde Foundation.

Dr. Robalo is Co-Chair of the UHC2030 Steering Committee and Vice Chair of the Ethics and Governance Committee of the Global Fund to fight AIDS, Tuberculosis and Malaria. Prior to these roles, Dr. Robalo was Director of Communicable Diseases, WHO Representative to Namibia and Ghana, Malaria Regional Advisor among other senior positions with the World Health Organization Africa Region. A leading voice for gender equality, she stands for equitable access to quality health care for all and social justice.

He has served on founding teams and boards of leading Asian companies in healthcare delivery, pharmaceuticals, API, medtech, and consumer healthcare such as Narayan Hrudayalaya, Fortis, HCG, Parkway Healthcare, AIG, Concord Biotech, Akums, Encube Ethicals, Hermina, Maxivision, and NephroPlus amongst others. He has co-sponsored HealthQuad, India’s largest healthtech venture capital firm to invest in early-stage ventures focussed on healthcare technology and innovation.

He maintains his passion as critical care physician through active involvement in academic and research endeavours. Amit is founder and mentor of one of Asia’s largest TeleICU network of over 500 ICU beds across India, Nepal, and Bangladesh. He is a visiting faculty at National University of Singapore (NUS) Business School. Previously, he was also an adjunct professor at University of Pittsburgh and Cleveland Clinic, USA.

To encourage investments and partnerships in local and global sustainable healthcare, he has been a member of the National Skill Council in India, Ayushman Bharat Digital Mission, and International Council at National University of Singapore (NUS) School of Medicine. He also serves on the board of Orbis international, a global non-profit non-governmental organisation dedicated to saving eyesight worldwide. Amit further devotes time and resources at Vimakr Foundation, his own philanthropic initiative for promoting women health and innovative healthcare solutions in rural India. He is also an active patron of and volunteer with Stranctuary Foundation, a non-profit animal rescue and welfare organisation in Alibaug, Maharashtra.

He holds an MBBS and MD qualification from the prestigious University of Delhi, India. He has received super-speciality medicine training from University of New York and University of Pittsburgh, USA and attended MBA courses at University of Chicago, USA.